[go: up one dir, main page]

MX9605367A - Aminometil-2,3,8,9-tetrahidro-7h-1, 4-dioxino[2,3-e]-indol-8 onas y derivados. - Google Patents

Aminometil-2,3,8,9-tetrahidro-7h-1, 4-dioxino[2,3-e]-indol-8 onas y derivados.

Info

Publication number
MX9605367A
MX9605367A MX9605367A MX9605367A MX9605367A MX 9605367 A MX9605367 A MX 9605367A MX 9605367 A MX9605367 A MX 9605367A MX 9605367 A MX9605367 A MX 9605367A MX 9605367 A MX9605367 A MX 9605367A
Authority
MX
Mexico
Prior art keywords
optionally substituted
alkyl
defined above
hydrogen
heteroaryl
Prior art date
Application number
MX9605367A
Other languages
English (en)
Inventor
Gary Paul Stack
Richard Eric Mewshaw
Byron Abel Bravo
Young Hee Kang
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of MX9605367A publication Critical patent/MX9605367A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Se describen los compuestos de la formula I: en donde R1 y R2 son, independientemente, hidrogeno, alquilo, fenilo o bencilo; o R1 y R2 tomados conjuntamente, son bencilideno opcionalmente substituidos con R3 como se define anteriormente o alquilideno, o R1 y R2, tomados conjuntamente con el átomo de carbono al cual están unidos, forman una porcion carbonilo o un grupo cicloalquilo; R3 es hidrogeno, hidroxi, halo, trifluorometilo, trifluorometoxi, alquilo, alcoxi, aralcoxi, alcanoiloxi, amino, mono-o di-alquilamino, alcanamido o alcansulfonamido; R4 es hidrogeno o alquilo; m es un numero entero 0, 1 o 2; n es un numero entero de 0 a 6, inclusive; Z es hidrogeno, hidroxi, alquilo, alquenilo, alquinilo, alcoxi, cicloalquilo, alquilo policíclico, fenilo opcionalmente substituido con R3 como se define anteriormente, fenoxi opcionalmente substituido con R3 como se define anteriormente, naftilo opcionalmente substituido con R3 como se define anteriormente, o naftiloxi opcionalmente substituido con R3 como se define anteriormente, heteroarilo o heteroariloxi, en los cuales el anillo heterocíclico el grupo heteroarilo o heteroariloxi se seleccionan de tiofeno, furano, piridina, pirazina, pirimidina, indol, indazol, imidazol, cromano, cumarina, carbostirilo, quinolina, bencisoxazol, benzoxazol, pirazol, pirrol, tiazol, oxazol, o isoxazol y el anillo heterocíclico está opcionalmente substituido con R3 como se define anteriormente; o una sal farmacéuticamente aceptable de los mismos, que son utiles en el tratamiento de desordenes del sistema dopaminérgico.
MX9605367A 1995-11-06 1996-11-05 Aminometil-2,3,8,9-tetrahidro-7h-1, 4-dioxino[2,3-e]-indol-8 onas y derivados. MX9605367A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US728395P 1995-11-06 1995-11-06
US08/730,267 US5756532A (en) 1995-11-06 1996-10-15 Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives

Publications (1)

Publication Number Publication Date
MX9605367A true MX9605367A (es) 1997-10-31

Family

ID=26676776

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9605367A MX9605367A (es) 1995-11-06 1996-11-05 Aminometil-2,3,8,9-tetrahidro-7h-1, 4-dioxino[2,3-e]-indol-8 onas y derivados.

Country Status (21)

Country Link
US (2) US5756532A (es)
EP (3) EP1375503B1 (es)
JP (1) JP4311770B2 (es)
KR (1) KR100566678B1 (es)
CN (1) CN1084748C (es)
AR (2) AR004284A1 (es)
AT (1) ATE349450T1 (es)
AU (1) AU701624B2 (es)
CA (1) CA2189524C (es)
CZ (1) CZ291731B6 (es)
DE (1) DE69636801T2 (es)
DK (1) DK1375503T3 (es)
ES (1) ES2277014T3 (es)
HU (1) HU224841B1 (es)
IL (1) IL119565A (es)
MX (1) MX9605367A (es)
NO (1) NO317054B1 (es)
NZ (1) NZ299693A (es)
PT (1) PT1375503E (es)
RU (1) RU2178416C2 (es)
SK (1) SK282168B6 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents
GB9704948D0 (en) 1997-03-11 1997-04-30 Knoll Ag Therapeutic agents
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles
US6350773B1 (en) * 1999-12-10 2002-02-26 American Home Products Corporation Therapeutic combinations of (S)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro 7H-1,4-dioxino{2,3-e}indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders
EA005002B1 (ru) 1999-12-10 2004-10-28 Уайт НОВЫЕ ТЕРАПЕВТИЧЕСКИЕ КОМБИНАЦИИ (S)-2-(БЕНЗИЛАМИНОМЕТИЛ)-2,3,8,9-ТЕТРАГИДРО-7H-1,4-ДИОКСИН [2,3-e]ИНДОЛ-8-ОНА И НЕЙРОЛЕПТИКОВ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРЕДОТВРАЩЕНИЯ ПСИХОТИЧЕСКИХ РАССТРОЙСТВ
US20060287335A1 (en) * 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
US6458802B1 (en) 2001-03-14 2002-10-01 Wyeth Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-f]quinoline
US6803368B2 (en) 2001-04-25 2004-10-12 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naphthalene
US6861434B2 (en) 2001-04-26 2005-03-01 Wyeth Antipsychotic aminomethyl derivatives of 1,3,7,8-tetrahydro-6,9-dioxa-1,3-diaza-cyclopenta[a]-naphthalen-2-one
CA2445552A1 (en) * 2001-04-26 2002-11-07 Wyeth Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta[a]naphthalene
EP1381612A1 (en) 2001-04-26 2004-01-21 Wyeth Antidepressant aza-heterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
US6800642B2 (en) 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-2,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
US7008944B2 (en) * 2001-04-26 2006-03-07 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-Dioxino[2,3-f]quinoxaline
US6927226B2 (en) 2001-04-26 2005-08-09 Wyeth Antidepressant azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene
US6861427B2 (en) * 2001-04-26 2005-03-01 Wyeth Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-HT1A antagonists
US6821981B2 (en) 2001-04-26 2004-11-23 Wyeth Azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]-quinoline as 5-HT1A antagonists
DE60213576T2 (de) * 2001-04-26 2007-10-18 Wyeth ANTIDEPRESSIVE AZAHETEROCYCLYLMETHYL-DERIVATE VON 2,3-DIHYDRO-1,4-DIOXINO-(2,3f)CHINOXALIN
US6800648B2 (en) 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-1,6,9-trioxa-3-AZA-cyclopenta[a]naphthalen-2-one
US6800641B2 (en) 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-2,3-diaza-cyclopenta[a]naphthalene
US6555560B2 (en) 2001-04-30 2003-04-29 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
US6906206B2 (en) 2001-04-30 2005-06-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
EP1387845A2 (en) * 2001-05-17 2004-02-11 Wyeth PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-(2,3-f) QUINOLINE
US6541502B1 (en) 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
US6541501B2 (en) 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
US6903110B2 (en) 2001-07-25 2005-06-07 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene
CN100352820C (zh) * 2002-09-12 2007-12-05 惠氏公司 抗抑郁的杂环稠合的苯并二噁烷的氮杂环甲基衍生物
US6939877B2 (en) * 2002-09-12 2005-09-06 Wyeth Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
US6800637B2 (en) * 2002-09-12 2004-10-05 Wyeth Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
US7135479B2 (en) 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
US7153849B2 (en) * 2002-09-12 2006-12-26 Wyeth Antidepressant arylpiperazine derivatives of hetrocycle-fused benzodioxans
PE20050484A1 (es) 2003-10-29 2005-10-13 Wyeth Corp Composicion farmaceutica de liberacion sostenida
US7297704B2 (en) 2005-02-17 2007-11-20 Wyeth Cycloalkyfused indole, benzothiophene, benzofuran and idene derivatives
TW200700413A (en) * 2005-03-01 2007-01-01 Wyeth Corp Crystalline and amorphous 4-cyano-n-{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride
CN101198322A (zh) * 2005-04-22 2008-06-11 惠氏公司 用于治疗或预防抑郁症的新治疗组合
TW200811182A (en) 2006-05-25 2008-03-01 Wyeth Corp Oxindoledioxans, synthesis thereof, and intermediates thereto
WO2008118935A1 (en) * 2007-03-26 2008-10-02 Neurogen Corporation Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-ones
ES2553645T3 (es) 2009-03-30 2015-12-10 Vtv Therapeutics Llc Derivados sustituidos de azoantraceno, composiciones farmacéuticas y métodos de uso de los mismos
RU2554883C1 (ru) * 2014-05-27 2015-06-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) Применение производных ацеталей пиридоксина в качестве антагонистов пуринорецепторов
RU2554885C1 (ru) * 2014-05-27 2015-06-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) Антагонисты пуринорецепторов на основе новых производных пиридоксина

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05505599A (ja) * 1990-03-15 1993-08-19 ジ・アップジョン・カンパニー 治療上有用な複素環インドール化合物類
US5126366A (en) * 1991-06-21 1992-06-30 American Home Products Corporation Aminophenoxyalkyl derivatives of benzodioxan
US5166367A (en) * 1991-06-21 1992-11-24 American Home Products Corporation Antipsychotic benzodioxan derivatives
US5189171A (en) * 1991-06-21 1993-02-23 American Home Products Corporation Antipsychotic benzodioxan derivatives
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
US5235055A (en) * 1992-09-02 1993-08-10 American Home Products Corporation Antipsychotic quinoline derivatives of benzodioxanmethylamine
US5245051A (en) * 1992-09-03 1993-09-14 American Home Products Corporation Antipsychotic chroman derivatives of benzodioxanmethylamine

Also Published As

Publication number Publication date
AU7055396A (en) 1997-05-15
EP1726592A1 (en) 2006-11-29
CN1084748C (zh) 2002-05-15
HU9603057D0 (en) 1996-12-30
EP1375503B1 (en) 2006-12-27
IL119565A (en) 2002-11-10
CA2189524C (en) 2007-05-01
EP0771800A3 (en) 1998-01-28
SK282168B6 (sk) 2001-11-06
EP1375503A1 (en) 2004-01-02
US5962465A (en) 1999-10-05
NZ299693A (en) 1997-09-22
KR970027068A (ko) 1997-06-24
US5756532A (en) 1998-05-26
JPH09249671A (ja) 1997-09-22
SK141496A3 (en) 1997-08-06
NO317054B1 (no) 2004-08-02
KR100566678B1 (ko) 2006-11-30
EP0771800A2 (en) 1997-05-07
JP4311770B2 (ja) 2009-08-12
CA2189524A1 (en) 1997-05-07
DK1375503T3 (da) 2007-01-22
HU224841B1 (en) 2006-03-28
CZ291731B6 (cs) 2003-05-14
IL119565A0 (en) 1997-03-18
ATE349450T1 (de) 2007-01-15
CN1155546A (zh) 1997-07-30
NO964686L (no) 1997-05-07
ES2277014T3 (es) 2007-07-01
DE69636801T2 (de) 2007-04-26
RU2178416C2 (ru) 2002-01-20
PT1375503E (pt) 2007-03-30
NO964686D0 (no) 1996-11-05
CZ324196A3 (en) 1997-12-17
AR004284A1 (es) 1998-11-04
AU701624B2 (en) 1999-02-04
HUP9603057A3 (en) 1998-12-28
DE69636801D1 (de) 2007-02-08
HUP9603057A2 (en) 1997-05-28
AR025698A1 (es) 2002-12-11

Similar Documents

Publication Publication Date Title
MX9605367A (es) Aminometil-2,3,8,9-tetrahidro-7h-1, 4-dioxino[2,3-e]-indol-8 onas y derivados.
HU905970D0 (en) Process for producing pyrazol derivatives
MX9804107A (es) Derivados de quinolina.
HUT64336A (en) Methods for producing new thiazole-benzofurane derivatives and pharmaceutical preparatives containing them
GB9413975D0 (en) New heterobicyclic derivatives
IE831335L (en) 3, 5-disubstituted indoles.
MX9800577A (es) Derivados de 4,5-diaril oxazol.
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
AU5289296A (en) Novel 4,6-diarylpyrimidine derivatives and salts thereof
NZ329303A (en) 1,10-dioxo-4-hydroxy-1,2,5,10-tetrahydro pyridazino[4,5-b] quinoline derivatives and medicaments
IL127668A0 (en) Indole derivatives for the treatment of osteoporosis
NZ332321A (en) 3-Descladinose-2,3-anhydroerythromycin derivatives and medicaments
DE69722020D1 (de) Azaheterocyclylmethyl-derivate von 2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-on
IL97429A0 (en) Substituted urea compounds,their preparation and pharmaceutical compositions comprising them
TW337523B (en) Aminomethyl-2, 3, 8,9-tetrahydro-7H-1, 4-dioxino (2, 3-e)-indol-8-ones and derivatives
AU561772B2 (en) Cyclobutyl methylamine derivatives
CA2230824A1 (en) Process for the preparation of galanthamine and its derivatives
CA2093631A1 (en) Pyrroloazepine derivative
AR019390A1 (es) Derivados de acidos sulfonilaminofosfinicos y sulfonilaminofosfonicos, procedimiento para su preparacion, compuestos intermediarios, medicamentos, procedimiento para su preparacion y empleo de dichos derivados para la preparacion de un medicamento.
FI893570A (fi) Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi
NZ336969A (en) Substituted 4-aminoalkoxy-1H-benzimidazole derivatives useful as dopamine autoreceptor (D2) agonists
UY25965A1 (es) Aminometil-2 3 8 9-tetrahidro-7h-1 4-dioxino[2 3 e]-indol-8- onas y derivados
EP0513398A4 (en) Intermediate for synthesis of carbapenem and production of said intermediate